Summary & Overview
CPT 68200: Subconjunctival Injection for Ocular Therapy
Headline: CPT code 68200: Subconjunctival Injection for Ocular Therapy
Lead: CPT code 68200 designates a subconjunctival injection — a focused ophthalmic procedure used to deliver antibiotics or anti-inflammatory agents directly beneath the conjunctiva. The code captures a common, targeted treatment for infectious or inflammatory eye conditions and is performed in outpatient ophthalmology settings and emergency departments.
CPT code 68200 matters nationally because it represents an often-utilized, low-complexity ophthalmic intervention that intersects acute care and outpatient specialty services. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise policy and billing summary, clinical context for appropriate use, and comparisons of coding practice across major payers where available. The publication outlines typical sites of service, common clinical indications, and considerations for providers and billing staff when documenting and submitting claims for this procedure.
What readers will learn: the clinical purpose and typical settings for CPT code 68200, which payers commonly cover the service, and where to find payer-specific guidance or coverage notes. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 68200 describes injection of medication into the subconjunctival space, commonly used to deliver antibiotics or to reduce periocular swelling. The procedure involves a provider administering a therapeutic agent beneath the conjunctiva to target ocular tissues directly.
-
Service type: Ophthalmic injection, therapeutic medication delivery
-
Typical site of service: Ambulatory ophthalmology clinic, emergency department, or outpatient procedure setting
Clinical & Coding Specifications
Clinical Context
A typical patient is a 62-year-old who presents to an ophthalmology clinic with a localized bacterial conjunctivitis and associated periorbital swelling after cataract surgery. The ophthalmologist evaluates the eye, documents the indication for local antibiotic delivery and/or anti-inflammatory therapy, obtains informed consent, and prepares the sterile field. Using topical anesthesia and antisepsis, the provider injects a small volume of medication into the subconjunctival space to achieve high local drug concentration and to treat infection or reduce postoperative inflammation. The procedure is commonly performed in an ambulatory ophthalmology clinic, hospital outpatient department, or ambulatory surgical center. Vital signs are monitored before and after the injection; the eye is examined for immediate complications such as hemorrhage or increased intraocular pressure. Follow-up instructions include signs of infection, pain control, and return precautions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day | Use when a distinct E/M visit is provided on the same day as the procedure (if applicable). |
50 | Bilateral procedure |